CTOR - Wutah bathi EPS kuartalan Citius Oncology

Logo grafis Citius Oncology Inc. (CTOR)

The quarterly EPS growth rate demonstrates profit dynamics, where the -10.40 level represents the current value. Citius Oncology, Inc. (CTOR) relies on the exclusivity of the drug Lymphir, which ensures high margins and a stable cash flow. The company is developing niche therapies for rare blood lymphomas in preparation for mass sales. The safety of clinical trials is guaranteed by strict control over medication logistics.

citiusonc.com (CTOR) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan saka 14.08.2024 nganti 16.11.2026

Citius Oncology, Inc. - rincian analitis lan metrik utama (CTOR)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:Citius Oncology Inc., CTOR
Produk dadi Citius Oncology Inc

Professional investors select resilient securities by analyzing net profit dynamics. This metric measures the percentage change in earnings per share (EPS) per quarter, reflecting the actual scaling speed of the business. The current quarterly EPS growth value helps identify the risk of overpaying for an asset during an anomalous acceleration of indicators. For Citius Oncology, Inc. (CTOR), the stability of this indicator is confirmed by the diversification of its oncology programs. Distributed stages of clinical trials minimize regulatory risks, supporting the company's fundamental value.

Analisis pesaing

ONC: Wutah bathi EPS kuartalan|Halozyme Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|RVMD (Revolution Medicines Inc) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Ascentage Pharma Group AAPG|Wutah bathi EPS kuartalan CGON|Wutah bathi EPS kuartalan UroGen Pharma Ltd (URGN)|Wutah bathi EPS kuartalan BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Erasca Oncology - Wutah bathi EPS kuartalan|DCTH: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|YMAB: Wutah bathi EPS kuartalan|Aura Bio (AURA) - Wutah bathi EPS kuartalan|CADL (Candel Therapeutics Inc.) - Wutah bathi EPS kuartalan|ARAY: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SLS (SELLAS Life Sciences Group, Inc.)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ACTU|TuHURA Biosciences, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan Protara TARA|fatetherapeutics.com - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aadi Bioscience|TCRX: Wutah bathi EPS kuartalan|CSBR - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|XBIT (XBiotech) - Wutah bathi EPS kuartalan|CVM: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan OSTX|RADX (Radiopharm Theranostics Limited) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ARTV (Artiva Biotherapeutics, Inc.)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ANL|VERU: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|TPST - Wutah bathi EPS kuartalan|XLO (xiliotx.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Renovaro Biosciences - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan MURA|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan KAPA|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OKUR (OnKure Therapeutics Inc)|Wutah bathi EPS kuartalan CytoMed (GDTC)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan curis.com CRIS|APLM (Apollomics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Tharimmune Corporation - Wutah bathi EPS kuartalan|ADVB (advanbiomed.com) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Genprex, Inc (GNPX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CLDI: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|SBFM (Sunshine Biopharma, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan XBIO (Xenetic Biosciences)|Wutah bathi EPS kuartalan SLRX|Purple Biotech - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|American Oncology Network - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan BGNE|CKPT - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Elevation Oncology (ELEV) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ICAD: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Viracta Therapeutics (VIRX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan AAPGV (Ascentage)